Hyman to lead Broad research center
Hyman to lead Broad research center
Former provost named director of Stanley Center for Psychiatric Research
Steven E. Hyman, a Harvard-trained neuroscientist, University provost for a decade, and the former director of the National Institute of Mental Health, has been named director of the Broad Institute’s Stanley Center for Psychiatric Research, effective Feb. 15.
Hyman, the Distinguished Service Professor of Stem Cell and Regenerative Biology (SCRB) at Harvard, succeeds Edward Scolnick, the founding director of the Stanley Center, who launched the center in 2007 after a distinguished career spanning psychiatric disease research, drug discovery and development, cancer research, and molecular biology. Scolnick will remain a core faculty member of the Broad and will become chief scientist at the Stanley Center.
“Steve Hyman is an extraordinary leader who brings remarkable expertise in neuroscience and scientific leadership as well as a deep understanding of the Broad Institute to his new role as director of the Stanley Center,” said Eric Lander, director of the Broad Institute. “Under Ed Scolnick’s leadership, the pioneering efforts of the Stanley Center have been truly remarkable. With Steve’s guidance, the center will build on this extraordinary foundation to understand the mechanisms of psychiatric disease.”
The Stanley Center’s mission is to decrease the burden of serious neuropsychiatric illnesses by bringing the insights of modern genomics and genetics to bear on neurobiology and therapeutics. It was founded to address schizophrenia, bipolar disorder, and other mental illnesses. With the growing recognition that risk-causing genetic variants extend across multiple disorders of the brain, the center has also taken on the genetics of autism and other developmental disorders. Hyman joined the Broad as a scholar-in-residence at the Stanley Center last June, when he stepped down after 10 years as Harvard’s provost.
“I am privileged to assume the leadership of this visionary center created by Ed Scolnick and the Stanley Medical Research Institute,” said Hyman. “Because therapeutics for neuropsychiatric disorders have been stalled for decades, and are being abandoned by many pharmaceutical companies, such an effort has never been more important. I am dedicated to the application of modern genomic and biological tools to understanding these terrible illnesses and, above all, advancing treatment discovery.
Hyman will continue to teach undergraduate, graduate, and medical students at Harvard in his capacity as an SCRB professor.
From 1996 to 2001, Hyman also served as director of the National Institute of Mental Health (NIMH), where he focused on efforts to integrate genetics, molecular biology, neuroscience, and behavioral science into a broader understanding of mental illness.
From 2001 to 2011, Hyman served as Harvard University provost. During that time, he developed collaborative scientific initiatives that span multiple disciplines and institutions, and he was a key architect of the Broad Institute.
Scolnick, the founding director of the Stanley Center, will continue to play an important role at the Broad Institute. A physician-scientist who is a member of the National Academy of Sciences, Scolnick served as president of Merck Research Laboratories from 1982 to 2003, where he led efforts to develop 29 new drugs and other therapeutics. He served as the Stanley Center’s director for five years.
“Steve and I have worked together for many years and I have the deepest respect for his commitment to finding the causes of devastating psychiatric illnesses and developing new treatments,” said Scolnick. “He has a keen understanding of the goals of the Stanley Center and the challenges that lie ahead for psychiatric disease research. With his direction, we are in the best position to meet them.”
The Stanley Center was launched in 2007 with a grant from the Stanley Medical Research Institute (SMRI). The SMRI extended the grant last spring, ensuring the center’s place in the biomedical field.
“Psychiatric illness is a critical area of research, representing an important and unmet need,” said David Altshuler, a founding core faculty member of the Broad, the Institute’s chief academic officer, and a professor of genetics and medicine at Harvard Medical School and Massachusetts General Hospital. “The Broad community is thrilled that Steve will assume leadership of the Stanley Center and that Ed will continue to support and guide the center’s efforts as its chief scientist.”
Photo by Stephanie Mitchell/Harvard Staff Photographer
About Harvard Medical School (HMS)
Driving Change. Building Momentum. Making History.
“Since 1872, Harvard Medical School has been the incubator of bold ideas—a place where extraordinary people advance education, science and health care with unrelenting passion.
Whether training tomorrow’s doctors and scientists, decoding the fundamental nature of life, advancing patient care or improving health delivery systems around the world, we are never at rest. Allied with some of the world’s best hospitals, research institutes and a University synonymous with excellence, the School’s mission remains as ambitious as it is honorable: to alleviate human suffering caused by disease.”
About Harvard School of Public Health (HSPH)
Harvard School of Public Health is dedicated to advancing the public’s health through learning, discovery and communication. More than 400 faculty members are engaged in teaching and training the 1,000-plus student body in a broad spectrum of disciplines crucial to the health and well being of individuals and populations around the world. Programs and projects range from the molecular biology of AIDS vaccines to the epidemiology of cancer; from risk analysis to violence prevention; from maternal and children’s health to quality of care measurement; from health care management to international health and human rights.
About Harvard University.
Established in 1636, Harvard is the oldest institution of higher education in the United States. The University, which is based in Cambridge and Boston, Massachusetts, has an enrollment of over 20,000 degree candidates, including undergraduate, graduate, and professional students. Harvard has more than 360,000 alumni around the world.
Harvard University is devoted to excellence in teaching, learning, and research, and to developing leaders in many disciplines who make a difference globally. Harvard faculty are engaged with teaching and research to push the boundaries of human knowledge. For students who are excited to investigate the biggest issues of the 21st century, Harvard offers an unparalleled student experience and a generous financial aid program, with over $160 million awarded to more than 60% of our undergraduate students. The University has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a truly global education.
‘Universities nurture the hopes of the world: in solving challenges that cross borders; in unlocking and harnessing new knowledge; in building cultural and political understanding; and in modeling environments that promote dialogue and debate… The ideal and breadth of liberal education that embraces the humanities and arts as well as the social and natural sciences is at the core of Harvard’s philosophy. ’/ Drew Gilpin Faust
* The above story is adapted from materials provided by Harvard University